Sponsor
Deuteroncology
Clos Chanmurly 13, 4000 Liege, Belgium
About the sponsor
DeuterOncology’s clinical research includes treatment-focused studies in advanced and refractory solid tumours, with activity extending to patients with locally advanced unresectable or metastatic non-small cell lung cancer (NSCLC).
- Advanced solid tumours
- Refractory cancer
- Metastatic NSCLC
The sponsor’s oncology portfolio is centred on MET kinase inhibition and cancer settings where standard treatment options remain limited.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.